01-08-1999 | ORIGINAL ARTICLE
A multi-centre randomized phase II study of nolatrexed versus doxorubicin in treatment of Chinese patients with advanced hepatocellular carcinoma
Published in: Cancer Chemotherapy and Pharmacology | Issue 4/1999
Login to get access